A Cost-Benefit Comparison of Biparametric Magnetic Resonance Imaging Versus Conventional Prostate Cancer Screening
Jung Sik Huh, Kyung Kgi Park
J Urol Oncol. 2023;21(2):121-127.   Published online 2023 Jul 31     DOI: https://doi.org/10.22465/juo.224400600030
Citations to this article as recorded by Crossref logo
Is biparametric MRI a feasible option for detecting clinically significant prostate cancer?: A systematic review and meta-analysis
Carlos A. Garcia-Becerra, Maria I. Arias-Gallardo, Veronica Soltero-Molinar, Jesus E. Juarez-Garcia, Mariabelen I. Rivera-Rocha, Luis F. Parra-Camaño, Natalia Garcia-Becerra, Carlos M. Garcia-Gutierrez
Urologic Oncology: Seminars and Original Investiga.2025;[Epub]     CrossRef
This Month’s Issue of JUO
Cheol Kwak
Journal of Urologic Oncology.2023; 21(2): 95.     CrossRef